FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35860111000001104: Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110886701000001119 Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110886801000001111 Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Preservative free true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Is a Ciprofloxacin 3mg/ml / Fluocinolone acetonide 0.25mg/ml ear drops 0.25ml unit dose preservative free true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has specific active ingredient Ciprofloxacin hydrochloride true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has specific active ingredient Fluocinolone acetonide true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has dispensed dose form Conventional release ear drops true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has unit of administration drop false Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Is a Cetraxal Plus true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has active ingredient Ciprofloxacin true Inferred relationship Existential restriction modifier
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Has active ingredient Fluocinolone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses Has AMP True Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start